Home › Conditions › Disseminated Intravascular Coagulation (DIC)
haematology
Disseminated Intravascular Coagulation (DIC)
DIC is a consumptive coagulopathy characterised by simultaneous microvascular thrombosis and haemorrhage. The ISTH score ≥5 indicates overt DIC. The single most important step is treating the underlying cause — all haematological support is a bridge.
ISTH DIC Scoring Algorithm
The pathway
1 · Diagnose and score (ISTH)
- Platelet count: >100 = 0, 50–100 = 1, <50 = 2
- PT prolongation: <3s = 0, 3–6s = 1, >6s = 2
- Fibrinogen: >1g/L = 0, <1g/L = 1
- D-dimer/FDPs: no increase = 0, moderate increase = 2, strong increase = 3
- Score ≥5 = overt DIC; repeat daily if score 4
2 · Treat the underlying cause
- Sepsis: cultures + broad-spectrum antibiotics immediately
- Obstetric: delivery of placental products
- APML: ATRA (all-trans retinoic acid) urgently — reduces DIC-related mortality
- Trauma: haemorrhage control, damage-control resuscitation
3 · Correct haemostasis if actively bleeding
- FFP 15ml/kg IV to replace clotting factors
- Cryoprecipitate (2 pools = 10 units) if fibrinogen <1.5g/L
- Platelet transfusion if platelets <50 × 10⁹/L with active bleeding (or <20 if no bleeding)
4 · Fibrinogen replacement
- Cryoprecipitate preferred over FFP for fibrinogen replacement
- Target fibrinogen >1.5g/L
- Fibrinogen concentrate (Riastap) 3–4g IV as alternative if cryoprecipitate unavailable
5 · Tranexamic acid (selective use)
- TXA 1g IV over 10 minutes: use in obstetric DIC (PPH)
- AVOID TXA in sepsis-related DIC — risk of microvascular thrombosis
- AVOID TXA in APML-related DIC
6 · Heparin (selective use only)
- AVOID heparin in most DIC
- Low-dose LMWH may be considered in predominantly thrombotic DIC (e.g. aortic aneurysm, dead fetus syndrome) after senior haematology review
7 · Monitoring
- Repeat FBC, PT/APTT, fibrinogen, D-dimer every 6 hours in active DIC
- Monitor urine output (renal microvascular involvement)
- Daily review of ISTH score
8 · Escalate and involve haematology
- All patients with overt DIC require urgent haematology input
- APML-related DIC: haematology + oncology same day
- Obstetric DIC: obstetrics + haematology + critical care team
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Fresh Frozen Plasma (FFP) | 15ml/kg | IV | First-line for active bleeding. Replaces all clotting factors. Each unit ~250ml — anticipate volume load. |
| Cryoprecipitate | 2 pools (10 units) | IV | Give if fibrinogen <1.5g/L. Each pool raises fibrinogen by ~0.5g/L. |
| Tranexamic acid | 1g over 10 minutes | IV | Obstetric DIC only. AVOID in sepsis-related or APML-related DIC. |
| ATRA (tretinoin) | 45mg/m²/day in divided doses | PO | APML-related DIC: start urgently. Reduces DIC by inducing differentiation of leukaemic promyelocytes. |
| Platelet concentrate | 1 adult therapeutic dose | IV | If platelets <50 × 10⁹/L with bleeding, or <20 × 10⁹/L prophylactically. |
When to escalate
ISTH DIC score ≥5 with active haemorrhage unresponsive to replacement,Fibrinogen <1g/L despite cryoprecipitate transfusion,Suspected APML (blast crisis, DIC in young patient with bleeding) — haematology emergency,Platelet count <20 × 10⁹/L in non-bleeding patient,Oliguria or rising creatinine suggesting renal microvascular involvement,Obstetric DIC with ongoing haemorrhage — activate major haemorrhage protocol
Reference: BSH Guidelines for the Diagnosis and Management of DIC 2009 (updated 2016)
This page is the reference half
The app adds what a web page cannot: a VINDICATE differential builder, worked on-call scenarios with full A–E findings, recall practice, and all of it offline.